Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-31

Clinical Trial Update: GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies [NA]

View source ↗

Summary

Clinical trial update for GAL1704 in cheek augmentation shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GAL1704 (GAL1704)

Snippet

Sponsor: Galderma R&D | Conditions: Cheek Augmentation | NA | Status: COMPLETED | Results posted: 2022-05-31